ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
ClearPoint Neuro Inc

ClearPoint Neuro Inc (CLPT)

5.43
0.10
(1.88%)
Closed April 30 4:00PM
5.43
0.00
( 0.00% )
Pre Market: 4:09AM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.501.705.000.003.350.000.00 %00-
5.000.550.700.650.6250.058.33 %50104/30/2024
7.500.040.150.040.0950.000.00 %071-
10.000.000.050.000.000.000.00 %00-

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.000.500.000.000.000.00 %00-
5.000.100.200.250.150.000.00 %062-
7.501.852.600.002.2250.000.00 %00-
10.004.405.200.004.800.000.00 %00-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PLTNPlutoniam Acquisition Corporation
$ 18.70
(111.30%)
21.97k
IMCCIM Cannabis Corporation
$ 1.27
(47.67%)
590.85k
POAIPredictive Oncology Inc
$ 1.86
(31.91%)
153.53k
ROOTRoot Inc
$ 88.80
(27.49%)
15
POWLPowell Industries Inc
$ 175.00
(22.38%)
102
CVRXCVRx Inc
$ 11.00
(-29.08%)
2.94k
KAVLKaival Brands Innovations Group Inc
$ 3.70
(-16.85%)
50
SOBRSOBR Safe Inc
$ 0.2563
(-14.57%)
4.49k
AMDLGraniteShares 2X Long AMD Daily ETF
$ 14.34
(-13.61%)
2.26k
GVVisionary Holdings Inc
$ 0.225
(-12.11%)
1.31k
IMCCIM Cannabis Corporation
$ 1.27
(47.67%)
590.85k
AKANAkanda Corporation
$ 0.0985
(5.91%)
326.18k
IBITiShares Bitcoin Trust ETF
$ 32.58
(-2.95%)
265.37k
SQQQProShares UltraPro Short QQQ
$ 12.14
(1.59%)
189.89k
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.16
(-2.04%)
175.43k

CLPT Discussion

View Posts
Mortimerduke Mortimerduke 3 months ago
Putting their funding to good use!
👍️0
MasterBlastr MasterBlastr 2 years ago
50% haircut last 6 months. Glad I didn't buy when you were hyping this. Looks like you are gone too.
👍️0
VMLG17 VMLG17 2 years ago
Plenty of talk of her on the NWBO board. I'm long on NWBO.
👍️0
oderwacher oderwacher 2 years ago
Doesn't anybody ever talk about Dr. Linda Liau?
👍️0
ronpopeil ronpopeil 3 years ago
I bought in. Very exciting company
👍️0
DayTraderOG DayTraderOG 3 years ago
Oh wow great dip time to scoop some shares on sale
👍️0
DayTraderOG DayTraderOG 3 years ago
Nice news clear point neuro doing big things saving our lives go $CLPT https://www.globenewswire.com/news-release/2021/01/26/2164680/0/en/ClearPoint-Neuro-Inc-Announces-Expansion-of-Pre-Clinical-and-Translational-Development-Team-to-Support-Gene-and-Stem-Cell-Therapy-Partners.html
👍️0
DayTraderOG DayTraderOG 3 years ago
This stock has been great runner daily
👍️0
DayTraderOG DayTraderOG 3 years ago
Everyone missing out on this great stock of the year
👍️0
DayTraderOG DayTraderOG 3 years ago
Good after noon CLPT
👍️0
DayTraderOG DayTraderOG 3 years ago
Going be great in am
👍️0
DayTraderOG DayTraderOG 3 years ago
Yall missed this gem
👍️0
DayTraderOG DayTraderOG 3 years ago
Wow from 7 to 23 if u missed me calling out CLPT where were u
👍️0
DayTraderOG DayTraderOG 3 years ago
Good morning clear point looks like shell be going 30 today by end of week
👍️0
DayTraderOG DayTraderOG 3 years ago
All new highs here anyone missing this ?? losing a lot of free cash
👍️0
MWM MWM 3 years ago
$CLPT very Nice! I have too many plays!!! Very Nice!

👍️0
DayTraderOG DayTraderOG 3 years ago
$CLPT
Keep going up
👍️0
DayTraderOG DayTraderOG 3 years ago
Yall missing out on all this love
👍️0
DayTraderOG DayTraderOG 3 years ago
I like this gem keeps going up like stair case this will be at $50 easy
👍️0
MWM MWM 3 years ago
ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms

https://www.globenewswire.com/news-release/2020/12/29/2151415/0/en/ClearPoint-Neuro-Inc-Announces-Funding-of-Additional-7-5M-of-Existing-Convertible-Note-on-Improved-Terms.html
👍️0
DayTraderOG DayTraderOG 3 years ago
Ive been in since July its been a great ride for me
👍️0
MWM MWM 3 years ago
Nice Find
👍️0
MWM MWM 3 years ago
CLPT one to watch...

Outstanding Shares 16,869,528 11/10/2020

Brain surgery

The Restore-1 trial DSMB did not advise Neurocrine's team to pause or halt the trial back in November, Roberts said. However, it did recommend that the company discontinue its use of the neurosurgical procedure used in the trial at the time, she said. That was presumably a reference to the brain surgery procedure by which NBIb-1817 and another Voyager asset, VY-HTT-01, are designed to be delivered to targeted areas and cells in the brain.

In a previous phase I trial, conducted by the University of California, San Francisco, three patients experienced hemorrhages caused by the surgical procedure for administering VY-AADC, Voyager reported in its most recent quarterly report, on Nov. 9.

In response, in Restore-1, investigators began using Clearpoint Neuro Inc.'s Clearpoint System "to provide accurate placement of the cannula in the putamen and allow for real-time, intra-operative MRI to assist the physician in visualizing the delivery of VY-AADC (NBIb-1817) to the putamen and to avoid specific blood vessels during the duration of the surgical procedure, with the goal of reducing the risk of hemorrhages," Voyager said.

In the same quarterly filing, Voyager said that it might begin using V-TAG, a real-time, intra-operative, MRI-compatible device that it developed with Clearpoint for the procedures.

Even with those changes, the Restore-1 study had been on pause since earlier in the year due to what Roberts called a "major amendment to the study over the course of the summer," one that appears to have included a major streamlining of the trial's primary and secondary outcome measures. Furthermore, screening for the study had been paused as well, particularly in light of the need for trial participants to travel, sometimes across state lines for study-relating brain scans.

Neurocrine's efforts to resolve those issues weren't clear on Wednesday. But Cowen analyst Phil Nadeau remained cautiously optimistic. "The risk to NBIb-1817's further development, as well as the duration of the delay, can't be estimated without understanding the specific issues that the DSMB has identified," he said.

https://www.bioworld.com/articles/501751-fda-puts-parkinsons-trial-on-hold-amid-imaging-abnormalities



👍️0
DayTraderOG DayTraderOG 3 years ago
Wow im glad I know about this gem steadily going up lets have another great say $CLPT
👍️0
DayTraderOG DayTraderOG 3 years ago
This stock will be at 50 dollars one day soon don't get left out this gem
👍️0
DayTraderOG DayTraderOG 3 years ago
Don't sleep on this ticker is the way of future surgery
👍️0
DayTraderOG DayTraderOG 3 years ago
Watching the dips today
👍️0

Your Recent History

Delayed Upgrade Clock